PROFOUND MED CORP PROF 深 滬
等待開盤 12-15 09:30:00 美东时间
7.33
-0.100
-1.35%
華盛通- 最 高7.39
- 今 開7.39
- 成交量 6.23万股
- 最 低 7.10
- 昨 收 7.43
- 總市值 2.20亿
- 52周最高 7.99
- 市盈率 靜 --
- 換手率 0.21%
- 52周最低 3.76
- 委 比 81.90%
- 總股本 3005.31万
- 歷史最高 28.97
- 量 比 0.77
- 振 幅 3.90%
- 歷史最低 3.10
- 每 手 1
- 風險率 0.99%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Profound Medical’s TULSA Procedure Gains Recognition at RSNA
Profound Medical ( ($TSE:PRN) ) has issued an announcement. Profound Medical Co...
12-05 06:44
Profound Medical To Launch TULSA-AI Volume Reduction Module For Optimizing Treatment Of Patients With Benign Prostatic Hyperplasia, Or Enlarged Prostate, At RSNA Meeting
Profound Medical Corp. (NASDAQ:PROF, TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of
11-28 20:47
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
Renowned urologist Dr. Mark Hong has achieved a global milestone by performing 200 independent TULSA Procedures using Profound Medical's TULSA-PRO system, revolutionizing MRI-guided prostate therapy. This milestone establishes a new model for incision-free prostate care, demonstrating that urologists alone can safely execute the full procedure, delivering personalized therapy with exceptional precision and preserving patients' quality of life. Th...
11-18 21:15
Profound Medical shares are trading lower. The company reported Q3 financial results.
Profound Medical shares are trading lower. The company reported Q3 financial re...
11-14 05:18
Profound Medical Q3 EPS $(0.26) Beats $(0.36) Estimate, Sales $5.289M Beat $4.995M Estimate
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.36) by 28.77 percent. This is a 31.58 percent increase over losses of $(0.38) per share from
11-14 05:11
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
Profound Medical Regains Exclusive Distribution Rights For TULSA-PRO From Knight Therapeutics In Canada
Profound Medical Corp. (NASDAQ:PROF, (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets artificial intelligence ("AI")-powered, MRI-guided,
11-11 05:33
Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026
Profusa has achieved key manufacturing milestones to support 2026 revenue targets for its Lumee tissue oxygen monitoring systems. The company completed its first sensor production run in a new controlled environment room, with capacity exceeding twice the 2026 requirements. It also engaged a contract manufacturer for Lumee patches/readers and pens, with production capacities exceeding demand. Distribution partnerships and clinical collaborations ...
10-28 12:30
IBM RELEASES THIRD-QUARTER RESULTS
Acceleration in revenue growth and profit across all segments; Raises outlook for full-year revenue growth and free cash flow ARMONK, N.Y., Oct. 22, 2025 /PRNewswire/ -- IBM (NYSE: IBM) toda...
10-23 04:08
Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH J...
10-22 19:00
